rct
    2017

    Clinical study on the effect of nattokinase on carotid artery atherosclerosis and hyperlipidaemia

    Ren NN, Chen HJ, Li Y, Lin YG

    Published in Zhonghua Yi Xue Za Zhi

    Key Findings

    Nattokinase 6000 FU/day for 26 weeks reduced carotid plaque size and improved lipid profile more than statin comparison in this trial.

    Conclusions

    Positive but methodologically weaker than the null NAPS trial.

    Limitations

    Open design, unclear randomisation.

    Supplements Studied

    Nattokinase reduced carotid plaque size and improved lipids in a lower-quality Chinese trial.

    Related Health Concerns

    Atherosclerosis

    Study Details

    Year:2017
    Sample Size:82
    Duration:26 weeks
    Quality Score:4/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.